Patents by Inventor Peter B. Carlsgaard

Peter B. Carlsgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulin dosage assessment and recommendation system
    Patent number: 9990581
    Abstract: A computer-implemented method is presented for recommending insulin dosage adjustments for a patient having diabetes. The method includes: identifying a plurality of bolus events from patient data; grouping bolus events having a recommended bolus dosage substantially equivalent to the amount of administered insulin into a first subset of bolus events; determining a bolus outcome for each of the bolus events in the first subset of bolus events, where the bolus outcome is expressed in relation to a target range of blood glucose values and is selected from a group including above the target range, in the target range and below the target range; determining whether one of the bolus outcomes is predominant amongst the bolus events in the first subset of bolus events; and generating a recommendation pertaining to insulin dosage for the patient in response to a determination that one of the bolus outcomes is predominant.
    Type: Grant
    Filed: July 11, 2012
    Date of Patent: June 5, 2018
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Peter B. Carlsgaard, Christen Rees, Robin S. Wagner
  • INSULIN DOSAGE ASSESSMENT AND RECOMMENDATION SYSTEM
    Publication number: 20140019396
    Abstract: A computer-implemented method is presented for recommending insulin dosage adjustments for a patient having diabetes. The method includes: identifying a plurality of bolus events from patient data; grouping bolus events having a recommended bolus dosage substantially equivalent to the amount of administered insulin into a first subset of bolus events; determining a bolus outcome for each of the bolus events in the first subset of bolus events, where the bolus outcome is expressed in relation to a target range of blood glucose values and is selected from a group including above the target range, in the target range and below the target range; determining whether one of the bolus outcomes is predominant amongst the bolus events in the first subset of bolus events; and generating a recommendation pertaining to insulin dosage for the patient in response to a determination that one of the bolus outcomes is predominant.
    Type: Application
    Filed: July 11, 2012
    Publication date: January 16, 2014
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Peter B. Carlsgaard, Christen Rees, Robin S. Wagner